Target intelligence / Profile preview

Urease enzyme from Helicobacter pylori

Molecular classification
Enzyme, Metalloenzyme, Nickel-dependent enzyme
01

Overview

Urease enzyme from Helicobacter pylori is a multi-subunit, nickel-dependent metalloenzyme essential for the bacterium’s survival in the acidic environment of the human stomach[3][5][6]. The enzyme rapidly hydrolyzes urea, which diffuses into the bacterial cytoplasm via a specialized proton-gated urea channel, forming ammonia and carbon dioxide[7]. The ammonia produced locally neutralizes gastric acid, allowing H. pylori to maintain intracellular and periplasmic pH homeostasis, which is vital for colonization and persistent infection[6][8]. Structurally, H. pylori urease is a dodecameric assembly containing 12 UreA and 12 UreB subunits, with the active site featuring two nickel ions bridged by a carbamylated lysine and surrounded by several histidines and an aspartate[1][7]. Maturation and activation of the enzyme require several accessory proteins (UreD, UreE, UreF, UreG, and UreH), responsible for nickel insertion and proper folding[2][3]. Because urease is both essential for gastric colonization and unique to H. pylori among stomach bacteria, it is a major target for diagnostic tests and drug development, and its inhibition is a validated strategy for eradicating H. pylori infection and ameliorating gastritis, ulcers, and some gastric cancers[1][7][6].

Other names
UreaseH. pylori ureaseHelicobacter pylori urease
02

Mechanism of action

Inhibition of urease active site, disruption of nickel binding or incorporation into the enzyme, and inhibition of urea hydrolysis, reducing ammonia production and acid resistance.

03

Biological functions

Urea hydrolysisAcid resistancepH homeostasis in bacteriaVirulence factor for bacterial survival
04

Disease associations

InfectionGastritisPeptic ulcer diseaseGastric cancerGastric MALT lymphoma
05

Safety considerations

Potential disruption of host urea metabolism if non-specific inhibitors are usedDevelopment of drug resistanceOff-target nickel chelation possibly affecting host nickel-dependent enzymes
06

Interacting drugs

Acetohydroxamic acid (AHA)

2 more in the full profile.

07

Biomarkers

Urea breath test (exhaled ^13CO_2 following oral urea), based on urease activityRapid urease test (biopsy-based detection of urease activity)

Beyond the preview

Go deeper on Urease enzyme from Helicobacter pylori.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Urease enzyme from Helicobacter pylori.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call